GSK is expected to report profit of £4.4 billion for the first half of this year. AstraZeneca is forecast to report a half-year profit of £5 billion.Read More

You might also be interested in reading XRP Holds Breakout as Global Macro Conditions Improve and Stronger Institutional Flows Support Further Upside.